Loading...
Header Logo
Keywords
Last Name
Institution

MICHAEL KROLL

TitleProfessor
InstitutionMD Anderson
DepartmentPulmonary Medicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    F32HL007608     (KROLL, MICHAEL H)Nov 1, 1987
    NIH/NHLBI
    CONTROL OF PLATELET SIGNAL TRANSDUCTION
    Role: Principal Investigator

    K08HL002311     (KROLL, MICHAEL H)Apr 1, 1989 - Mar 31, 1994
    NIH/NHLBI
    MECHANISMS ON VON WILLEBRAND FACTOR-INDUCED PLATELET ACT
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kroll MH. The AHR: adaptive evolution or one-off? Blood. 2019 Dec 26; 134(26):2337-2338. PMID: 31877215.
      View in: PubMed
    2. Chamoun K, Loghavi S, Pemmaraju N, Konopleva M, Kroll M, Nguyen-Cao M, Hornbaker M, DiNardo CD, Kadia T, Jorgensen J, Andreeff M, Hu S, Benton CB. Early detection of transformation to BPDCN in a patient with MDS. Exp Hematol Oncol. 2018; 7:26. PMID: 30323983.
      View in: PubMed
    3. Chen LS, Bose P, Cruz ND, Jiang Y, Wu Q, Thompson PA, Feng S, Kroll MH, Qiao W, Huang X, Jain N, Wierda WG, Keating MJ, Gandhi V. A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia. Blood. 2018 11 22; 132(21):2249-2259. PMID: 30254130.
      View in: PubMed
    4. Litwin RJ, Huang SY, Sabir SH, Hoang QB, Ahrar K, Ahrar J, Tam AL, Mahvash A, Ensor JE, Kroll M, Gupta S. Impact of an inferior vena cava filter retrieval algorithm on filter retrieval rates in a cancer population. J Vasc Surg Venous Lymphat Disord. 2017 09; 5(5):689-697. PMID: 28818223.
      View in: PubMed
    5. Huang SY, Odisio BC, Sabir SH, Ensor JE, Niekamp AS, Huynh TT, Kroll M, Gupta S. Development of a predictive model for 6 month survival in patients with venous thromboembolism and solid malignancy requiring IVC filter placement. J Thromb Thrombolysis. 2017 Jul; 44(1):30-37. PMID: 28315167.
      View in: PubMed
    6. Luong NV, Kroll MH, Vu K. Recurrence of venous thromboembolism among adults acute leukemia patients treated at the University of Texas MD Anderson Cancer Center: Incidence and risk factors. Thromb Res. 2017 Aug; 156:14-19. PMID: 28577388.
      View in: PubMed
    7. Feng S, Kroll MH, Nick AM, Sood AK, Afshar-Kharghan V. Platelets are not hyperreactive in patients with ovarian cancer. Platelets. 2016 Nov; 27(7):716-718. PMID: 27185008.
      View in: PubMed
    8. Maiti A, Short NJ, Kroll MH. Indiscriminate Testing for Heparin-Induced Thrombocytopenia: A Teachable Moment. JAMA Intern Med. 2016 05 01; 176(5):592-3. PMID: 27043083.
      View in: PubMed
    9. Shoultz-Henley S, Garden AS, Mohamed AS, Sheu T, Kroll MH, Rosenthal DI, Gunn GB, Hayes AJ, French C, Eichelberger H, Kalpathy-Cramer J, Smith BD, Phan J, Ayoub Z, Lai SY, Pham B, Kies M, Gold KA, Sturgis E, Fuller CD. Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. Int J Cancer. 2016 Mar 01; 138(5):1290-7. PMID: 26414107.
      View in: PubMed
    10. Alattar ML, Ciccone M, Gaballa MR, Vitale C, Badoux XC, Manoukian G, Keating MJ, Kroll MH, Ferrajoli A. Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2015; 56(12):3452-4. PMID: 25926060.
      View in: PubMed
    11. Prescott LS, Kidin LM, Downs RL, Cleveland DJ, Wilson GL, Munsell MF, DeJesus AY, Cain KE, Ramirez PT, Kroll MH, Levenback CF, Schmeler KM. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence. Int J Gynecol Cancer. 2015 Jan; 25(1):152-9. PMID: 25365592.
      View in: PubMed
    12. Kroll MH, Michaelis LC, Verstovsek S. Mechanisms of thrombogenesis in polycythemia vera. Blood Rev. 2015 Jul; 29(4):215-21. PMID: 25577686.
      View in: PubMed
    13. Vu K, Luong NV, Hubbard J, Zalpour A, Faderl S, Thomas DA, Yang D, Kantarjian H, Kroll MH. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center. Cancer Med. 2015 Jan; 4(1):27-35. PMID: 25487644.
      View in: PubMed
    14. Feng S, Liang X, Kroll MH, Chung DW, Afshar-Kharghan V. von Willebrand factor is a cofactor in complement regulation. Blood. 2015 Feb 05; 125(6):1034-7. PMID: 25395424.
      View in: PubMed
    15. Feng S, Liang X, Cruz MA, Vu H, Zhou Z, Pemmaraju N, Dong JF, Kroll MH, Afshar-Kharghan V. The interaction between factor H and Von Willebrand factor. PLoS One. 2013; 8(8):e73715. PMID: 23991205.
      View in: PubMed
    16. Feng S, Eyler SJ, Zhang Y, Maga T, Nester CM, Kroll MH, Smith RJ, Afshar-Kharghan V. Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. Blood. 2013 Aug 22; 122(8):1487-93. PMID: 23847193.
      View in: PubMed
    17. Schmeler KM, Wilson GL, Cain K, Munsell MF, Ramirez PT, Soliman PT, Nick AM, Frumovitz M, Coleman RL, Kroll MH, Levenback CF. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecol Oncol. 2013 Feb; 128(2):204-8. PMID: 23200912.
      View in: PubMed
    18. Feng S, Kroll MH, Nolasco L, Moake J, Afshar-Kharghan V. Complement activation in thrombotic microangiopathies. Br J Haematol. 2013 Feb; 160(3):404-6. PMID: 23116127.
      View in: PubMed
    19. Cho MS, Bottsford-Miller J, Vasquez HG, Stone R, Zand B, Kroll MH, Sood AK, Afshar-Kharghan V. Platelets increase the proliferation of ovarian cancer cells. Blood. 2012 Dec 06; 120(24):4869-72. PMID: 22966171.
      View in: PubMed
    20. Kroll MH, Afshar-Kharghan V. Platelets in pulmonary vascular physiology and pathology. Pulm Circ. 2012 Jul; 2(3):291-308. PMID: 23130099.
      View in: PubMed
    21. Ma Q, Li D, Nurieva R, Patenia R, Bassett R, Cao W, Alekseev AM, He H, Molldrem JJ, Kroll MH, Champlin RE, Sale GE, Afshar-Kharghan V. Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation. Biol Blood Marrow Transplant. 2012 Aug; 18(8):1174-81. PMID: 22664751.
      View in: PubMed
    22. Zalpour A, Kroll MH, Afshar-Kharghan V, Yusuf SW, Escalante C. Role of factor xa inhibitors in cancer-associated thrombosis: any new data? Adv Hematol. 2011; 2011:196135. PMID: 22013445.
      View in: PubMed
    23. Chavez-MacGregor M, Zhao H, Kroll M, Fang S, Zhang N, Hortobagyi GN, Buchholz TA, Shih YC, Giordano SH. Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer. Ann Oncol. 2011 Nov; 22(11):2394-402. PMID: 21393379.
      View in: PubMed
    24. Iliescu C, Durand JB, Kroll M. Cardiovascular interventions in thrombocytopenic cancer patients. Tex Heart Inst J. 2011; 38(3):259-60. PMID: 21720465.
      View in: PubMed
    25. Kroll MH. If Virchow were to meet Newton. Blood. 2010 Mar 18; 115(11):2123-4. PMID: 20299520.
      View in: PubMed
    26. Dong JF, Cruz MA, Aboulfatova K, Martin C, Choi H, Bergeron AL, Martini SR, Kroll MH, Kent TA. Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions. Thromb Haemost. 2008 Mar; 99(3):586-93. PMID: 18327408.
      View in: PubMed
    27. Reséndiz JC, Kroll MH, Lassila R. Protease-activated receptor-induced Akt activation--regulation and possible function. J Thromb Haemost. 2007 Dec; 5(12):2484-93. PMID: 17883592.
      View in: PubMed
    28. Feng S, Lu X, Reséndiz JC, Kroll MH. Pathological shear stress directly regulates platelet alphaIIbbeta3 signaling. Am J Physiol Cell Physiol. 2006 Dec; 291(6):C1346-54. PMID: 16822941.
      View in: PubMed
    29. Kroll MH, Feng S. Targeting shear stress-induced platelet activation: is lesion-specific antiplatelet therapy a realistic clinical goal? Expert Rev Cardiovasc Ther. 2005 Sep; 3(5):941-51. PMID: 16181038.
      View in: PubMed
    30. Hassan AA, Kroll MH. Acquired disorders of platelet function. Hematology Am Soc Hematol Educ Program. 2005; 403-8. PMID: 16304411.
      View in: PubMed
    31. Feng S, Lu X, Kroll MH. Filamin A binding stabilizes nascent glycoprotein Ibalpha trafficking and thereby enhances its surface expression. J Biol Chem. 2005 Feb 25; 280(8):6709-15. PMID: 15623510.
      View in: PubMed
    32. Sun L, Feng S, Reséndiz JC, Lu X, Durante W, Kroll MH. Role of the Pyk2-MAP kinase-cPLA2 signaling pathway in shear-dependent platelet aggregation. Ann Biomed Eng. 2004 Sep; 32(9):1193-201. PMID: 15493507.
      View in: PubMed
    33. Franceschi F, Christodoulides N, Kroll MH, Genta RM. Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med. 2004 May 04; 140(9):766-7. PMID: 15126268.
      View in: PubMed
    34. Reséndiz JC, Feng S, Ji G, Kroll MH. von Willebrand factor binding to platelet glycoprotein Ib-IX-V stimulates the assembly of an alpha-actinin-based signaling complex. J Thromb Haemost. 2004 Jan; 2(1):161-9. PMID: 14717980.
      View in: PubMed
    35. Feng S, Reséndiz JC, Lu X, Kroll MH. Filamin A binding to the cytoplasmic tail of glycoprotein Ibalpha regulates von Willebrand factor-induced platelet activation. Blood. 2003 Sep 15; 102(6):2122-9. PMID: 12791664.
      View in: PubMed
    36. Massarweh S, Udden MM, Shahab I, Kroll M, Sears DA, Lynch GR, Teh BS, Lu HH. HIV-related Hodgkin's disease with central nervous system involvement and association with Epstein-Barr virus. Am J Hematol. 2003 Mar; 72(3):216-9. PMID: 12605396.
      View in: PubMed
    37. Reséndiz JC, Feng S, Ji G, Francis KA, Berndt MC, Kroll MH. Purinergic P2Y12 receptor blockade inhibits shear-induced platelet phosphatidylinositol 3-kinase activation. Mol Pharmacol. 2003 Mar; 63(3):639-45. PMID: 12606772.
      View in: PubMed
    38. Vilchez RA, Jorgensen JL, Kroll MH. Systemic non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood. 2002 Jun 01; 99(11):4250-1. PMID: 12043698.
      View in: PubMed
    39. Anstadt MP, Carwile JM, Guill CK, Conklin LD, Soltero ER, Lucci A, Kroll MH. Relapse of thrombotic thrombocytopenic purpura associated with decreased VWF cleaving activity. Am J Med Sci. 2002 May; 323(5):281-4. PMID: 12018674.
      View in: PubMed
    40. Vilchez RA, Kozinetz CA, Jorgensen JL, Kroll MH, Butel JS. AIDS-related systemic non-Hodgkin's lymphoma at a large community program. AIDS Res Hum Retroviruses. 2002 Mar 01; 18(4):237-42. PMID: 11860669.
      View in: PubMed
    41. Feng S, Reséndiz JC, Christodoulides N, Lu X, Arboleda D, Berndt MC, Kroll MH. Pathological shear stress stimulates the tyrosine phosphorylation of alpha-actinin associated with the glycoprotein Ib-IX complex. Biochemistry. 2002 Jan 29; 41(4):1100-8. PMID: 11802708.
      View in: PubMed
    42. Christodoulides N, Feng S, Reséndiz JC, Berndt MC, Kroll MH. Glycoprotein Ib/IX/V binding to the membrane skeleton maintains shear-induced platelet aggregation. Thromb Res. 2001 Apr 15; 102(2):133-42. PMID: 11323024.
      View in: PubMed
    43. Feng S, Christodoulides N, Reséndiz JC, Berndt MC, Kroll MH. Cytoplasmic domains of GpIbalpha and GpIbbeta regulate 14-3-3zeta binding to GpIb/IX/V. Blood. 2000 Jan 15; 95(2):551-7. PMID: 10627461.
      View in: PubMed
    44. Feng S, Christodoulides N, Kroll MH. The glycoprotein Ib/IX complex regulates cell proliferation. Blood. 1999 Jun 15; 93(12):4256-63. PMID: 10361123.
      View in: PubMed
    45. Teh BS, Lu HH, Lynch GR, Banez E, Kroll MH. AIDS-related Kaposi's sarcoma involving bone and bone marrow. South Med J. 1999 Jan; 92(1):61-4. PMID: 9932830.
      View in: PubMed
    46. Kroll MH, Shandera WX. AIDS-associated Kaposi's sarcoma. Hosp Pract (1995). 1998 Apr 15; 33(4):85-8, 95-6, 99-102. PMID: 9562835.
      View in: PubMed
    47. Durante W, Kroll MH, Christodoulides N, Peyton KJ, Schafer AI. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res. 1997 Apr; 80(4):557-64. PMID: 9118487.
      View in: PubMed
    48. Andrews RK, Kroll MH, Ward CM, Rose JW, Scarborough RM, Smith AI, López JA, Berndt MC. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry. 1996 Sep 24; 35(38):12629-39. PMID: 8823201.
      View in: PubMed
    49. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood. 1996 Sep 01; 88(5):1525-41. PMID: 8781407.
      View in: PubMed
    50. Wagner CT, Kroll MH, Chow TW, Hellums JD, Schafer AI. Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions. Biorheology. 1996 May-Jun; 33(3):209-29. PMID: 8935180.
      View in: PubMed
    51. Durante W, Kroll MH, Orloff GJ, Cunningham JM, Scott-Burden T, Vanhoutte PM, Schafer AI. Regulation of interleukin-1-beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins. Biochem Pharmacol. 1996 Mar 22; 51(6):847-53. PMID: 8602881.
      View in: PubMed
    52. Razdan K, Kroll MH. Molecular cloning of a novel platelet protein showing homology to the angiotensin II receptor C-terminal domain. J Biol Chem. 1996 Jan 26; 271(4):2221-4. PMID: 8567682.
      View in: PubMed
    53. Sullivan R, Kunze DL, Kroll MH. Thrombin receptors activate potassium and chloride channels. Blood. 1996 Jan 15; 87(2):648-56. PMID: 8555487.
      View in: PubMed
    54. McCrary JK, Nolasco LH, Hellums JD, Kroll MH, Turner NA, Moake JL. Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress. Ann Biomed Eng. 1995 Nov-Dec; 23(6):787-93. PMID: 8572428.
      View in: PubMed
    55. Kamat SG, Michelson AD, Benoit SE, Moake JL, Rajasekhar D, Hellums JD, Kroll MH, Schafer AI. Fibrinolysis inhibits shear stress-induced platelet aggregation. Circulation. 1995 Sep 15; 92(6):1399-407. PMID: 7664419.
      View in: PubMed
    56. Christodoulides N, Durante W, Kroll MH, Schafer AI. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation. 1995 May 01; 91(9):2306-9. PMID: 7729015.
      View in: PubMed
    57. Razdan K, Hellums JD, Kroll MH. Shear-stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s). Biochem J. 1994 Sep 15; 302 ( Pt 3):681-6. PMID: 7524475.
      View in: PubMed
    58. Michelson AD, Benoit SE, Kroll MH, Li JM, Rohrer MJ, Kestin AS, Barnard MR. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Blood. 1994 Jun 15; 83(12):3562-73. PMID: 8204882.
      View in: PubMed
    59. Durante W, Schini VB, Kroll MH, Catovsky S, Scott-Burden T, White JG, Vanhoutte PM, Schafer AI. Platelets inhibit the induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells. Blood. 1994 Apr 01; 83(7):1831-8. PMID: 8142651.
      View in: PubMed
    60. Rumbaut RE, Kroll MH, Gyorkey F, Schafer AI. Acquired platelet storage pool deficiency due to severe valvular disease corrected by prosthetic valve replacement. Am J Hematol. 1994 Mar; 45(3):272-3. PMID: 8296805.
      View in: PubMed
    61. Guo Z, Weinstein MJ, Phillips MD, Kroll MH. M(r) 6,400 aurin tricarboxylic acid directly activates platelets. Thromb Res. 1993 Jul 01; 71(1):77-88. PMID: 8367837.
      View in: PubMed
    62. Kroll MH, Hellums JD, Guo Z, Durante W, Razdan K, Hrbolich JK, Schafer AI. Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem. 1993 Feb 15; 268(5):3520-4. PMID: 8429027.
      View in: PubMed
    63. Durante W, Schini VB, Catovsky S, Kroll MH, Vanhoutte PM, Schafer AI. Plasmin potentiates induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells. Am J Physiol. 1993 Feb; 264(2 Pt 2):H617-24. PMID: 8447474.
      View in: PubMed
    64. Schafer AI, Kroll MH. Nonatheromatous arterial thrombosis. Annu Rev Med. 1993; 44:155-70. PMID: 8476237.
      View in: PubMed
    65. Durante W, Schafer AI, Hrbolich JK, Claure RA, Mendelsohn ME, Kroll MH. Endothelium-derived Relaxing Factor Inhibits Shear Stress-induced Platelet Aggregation. Platelets. 1993; 4(3):135-40. PMID: 21043858.
      View in: PubMed
    66. Kroll MH, Mendelsohn ME, Miller JL, Ballen KK, Hrbolich JK, Schafer AI. Monoclonal antibody AG-1 initiates platelet activation by a pathway dependent on glycoprotein IIb-IIIa and extracellular calcium. Biochim Biophys Acta. 1992 Nov 17; 1137(3):248-56. PMID: 1332779.
      View in: PubMed
    67. Chow TW, Hellums JD, Moake JL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood. 1992 Jul 01; 80(1):113-20. PMID: 1611079.
      View in: PubMed
    68. Durante W, Kroll MH, Vanhoutte PM, Schafer AI. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Blood. 1992 Jan 01; 79(1):110-6. PMID: 1309423.
      View in: PubMed
    69. Durante W, Schini VB, Scott-Burden T, Junquero DC, Kroll MH, Vanhoutte PM, Schafer AI. Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells. Am J Physiol. 1991 Dec; 261(6 Pt 2):H2024-30. PMID: 1661096.
      View in: PubMed
    70. Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI. von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J Clin Invest. 1991 Nov; 88(5):1568-73. PMID: 1939645.
      View in: PubMed
    71. Luzzatto G, Kroll MH, Zavoico GB, Schafer AI. Regulation of the phosphoinositide cycle by Na+/H+ exchange and intracellular pH in human platelets. Biochim Biophys Acta. 1991 Jun 19; 1084(1):78-86. PMID: 1647205.
      View in: PubMed
    72. Hechtman DH, Kroll MH, Gimbrone MA, Schafer AI. Platelet interaction with vascular smooth muscle in synthesis of prostacyclin. Am J Physiol. 1991 May; 260(5 Pt 2):H1544-51. PMID: 1903602.
      View in: PubMed
    73. Kroll MH, Claure RE, Miller JL. The monoclonal antibody AG-1, a potent stimulator of human platelets, interacts with a low molecular weight GTP-binding protein. Biochem Biophys Res Commun. 1990 Sep 28; 171(3):1252-7. PMID: 2121139.
      View in: PubMed
    74. Kroll MH, Schafer AI. Biochemical mechanisms of platelet activation. Blood. 1989 Sep; 74(4):1181-95. PMID: 2669994.
      View in: PubMed
    75. Kroll MH, Zavoico GB, Schafer AI. Second messenger function of phosphatidic acid in platelet activation. J Cell Physiol. 1989 Jun; 139(3):558-64. PMID: 2738101.
      View in: PubMed
    76. Takayama H, Kroll MH, Gimbrone MA, Schafer AI. Turnover of eicosanoid precursor fatty acids among phospholipid classes and subclasses of cultured human umbilical vein endothelial cells. Biochem J. 1989 Mar 01; 258(2):427-34. PMID: 2495792.
      View in: PubMed
    77. Kroll MH, Zavoico GB, Schafer AI. Control of platelet protein kinase C activation by cyclic AMP. Biochim Biophys Acta. 1988 Jun 08; 970(1):61-7. PMID: 2835990.
      View in: PubMed
    78. Endothelium-derived relaxing factor inhibits shear stress-induced platelet aggregation. Platelets. 4:135-140.
    79. Alpha actinin binds to glycoprotein (GP) IBA and functions as an adapter for phosphoinositide (PI) 3-kinase in shear stress-activated platelets. Blood. 96.
    80. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Obstetrical and Gynecological Survey. 68:439-440.
    81. Mechanisms of thrombogenesis in polycythemia vera. Blood Reviews. 29:215-221.
    82. Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia. Leukemia and Lymphoma. 56:3452-3454.
    83. Acquired disorders of platelet function. 225-241.
    84. Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. International Journal of Cancer. 138:1290-1297.
    85. Streptokinase inhibits acute platelet thrombus formation in stenosed dog coronary arteries. Platelets. 2:145-152.
    86. Nitric oxide induces heme oxygenase-1 expression in vascular smooth muscle cells. FASEB Journal. 10.
    87. Platelets are not hyperreactive in patients with ovarian cancer. Platelets. 1-3.
    KROLL's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description